Swanson S, Mifflin T E, Boyd J C
Clin Chem. 1986 May;32(5):863-4.
Immediately after intravenous infusion of a high dose (concentration in serum greater than 1000 mumol/L) of methotrexate, the apparent conjugated bilirubin (Bc) concentrations in serum of two osteosarcoma patients, as measured by the Kodak Ektachem 400 analyzer, were greater than the corresponding total bilirubin concentrations, but decreased as the concentrations of methotrexate in serum decreased. In an interference study we found that methotrexate added to sera containing a wide range of basal Bc concentrations increased the measured Bc concentration in a linear and dose-related fashion. Methotrexate also interfered negatively with measurements of unconjugated bilirubin (Bu). The source of the interference appears to be an overlap in the absorption spectrum of methotrexate with Bc and Bu at 400 nm.
在静脉输注高剂量(血清浓度大于1000μmol/L)甲氨蝶呤后,通过柯达Ektachem 400分析仪测量,两名骨肉瘤患者血清中的表观结合胆红素(Bc)浓度高于相应的总胆红素浓度,但随着血清中甲氨蝶呤浓度的降低而降低。在一项干扰研究中,我们发现向含有广泛基础Bc浓度的血清中添加甲氨蝶呤会以线性和剂量相关的方式增加测量的Bc浓度。甲氨蝶呤还对未结合胆红素(Bu)的测量产生负干扰。干扰的来源似乎是甲氨蝶呤在400nm处与Bc和Bu的吸收光谱重叠。